Literature DB >> 27437211

Antibiogram of Salmonella Isolates: Time to Consider Antibiotic Salvage.

R Sharvani1, D K Dayanand2, Poornima Shenoy3, Pooja Sarmah1.   

Abstract

INTRODUCTION: Enteric fever is a major problem especially in developing countries. Timely and appropriate treatment plays a very important role in reducing the mortality. Fluoroquinolones and cephalosporins are the treatment options for enteric fever. Recent studies have shown that it is time to reconsider the use of earlier antibiotics. AIM: The study was aimed to know whether salvage is possible and to avoid treatment failures following fluoroquinolone usage.
MATERIALS AND METHODS: A one year retrospective data of Salmonella species isolated from 319 blood samples from our hospital and other diagnostic centers were studied. Demographic data, organism isolated and their changing pattern of antibiogram were analysed.
RESULTS: Out of 319 Salmonella isolates, 52.4% (167) was Salmonella typhi (S. typhi) and 47.6% (152) Salmonella paratyphi A (S. paratyphi A), with a male preponderance. Most of the salmonellae were isolated in the months of June and July, with the majority being in the 1-10 and 21-30 years age groups. Both species were highly susceptible to chloramphenicol (95.2% and 100%) followed by third generation cephalosporins (97% and 98%), cotrimoxazole (95.8% and 98.6%) and ampicillin (94.6% and 93.4%) respectively. Highest resistance was seen for nalidixic acid (90.4% and100%) among both S. typhi and S. paratyphi A isolates followed by ciprofloxacin (62.2% and 54.6%) respectively. MDR to first line drugs was observed in a small proportion of S. typhi (1.7%) only.
CONCLUSION: The frequency of isolation of S. typhi and S. paratyphi A are in equal proportion and enteric fever is more prevalent in younger age group. It is ideal to adopt bivalent vaccination in Universal immunization schedule. The isolates show sensitivity to first line drugs, paving the way for salvage of the earlier drugs. Cephalosporins still remain the treatment of choice in MDR salmonella isolates.

Entities:  

Keywords:  Cephalosporins; MDR; NAR; Salmonella paratyphi A; Salmonella typhi

Year:  2016        PMID: 27437211      PMCID: PMC4948387          DOI: 10.7860/JCDR/2016/18102.7753

Source DB:  PubMed          Journal:  J Clin Diagn Res        ISSN: 0973-709X


  12 in total

1.  Current perspectives of enteric fever: a hospital-based study from India.

Authors:  Mandeep Walia; Rajni Gaind; Rajesh Mehta; Premila Paul; Pushpa Aggarwal; Mani Kalaivani
Journal:  Ann Trop Paediatr       Date:  2005-09

2.  Rising prevalence of enteric fever due to multidrug-resistant Salmonella: an epidemiological study.

Authors:  Surinder Kumar; Meher Rizvi; Nidhika Berry
Journal:  J Med Microbiol       Date:  2008-10       Impact factor: 2.472

3.  Antimicrobial susceptibility of Salmonella Typhi in India.

Authors:  Kavita Nagshetty; Shivannavar T Channappa; Subhashchandra M Gaddad
Journal:  J Infect Dev Ctries       Date:  2010-03-08       Impact factor: 0.968

Review 4.  Multidrug-resistant typhoid fever: a review.

Authors:  Syed Ahmed Zaki; Sunil Karande
Journal:  J Infect Dev Ctries       Date:  2011-05-28       Impact factor: 0.968

5.  Re-emerging chloramphenicol sensitivity and emerging low level ciprofloxacin resistance among Salmonella enterica serotype typhi isolates in North India.

Authors:  Varsha Gupta; Jaspal Kaur; Neelam Kaistha
Journal:  Trop Doct       Date:  2009-01       Impact factor: 0.731

6.  Reduced minimum inhibitory concentration of chloramphenicol for Salmonella enterica serovar typhi.

Authors:  S Mandal; M D Mandal; N K Pal
Journal:  Indian J Med Sci       Date:  2004-01

7.  Gatifloxacin versus chloramphenicol for uncomplicated enteric fever: an open-label, randomised, controlled trial.

Authors:  Amit Arjyal; Buddha Basnyat; Samir Koirala; Abhilasha Karkey; Sabina Dongol; Krishna Kumar Agrawaal; Nikki Shakya; Kabina Shrestha; Manish Sharma; Sanju Lama; Kasturi Shrestha; Nely Shrestha Khatri; Umesh Shrestha; James I Campbell; Stephen Baker; Jeremy Farrar; Marcel Wolbers; Christiane Dolecek
Journal:  Lancet Infect Dis       Date:  2011-04-29       Impact factor: 25.071

8.  Occurrence & antibiogram of Salmonella Typhi & S. Paratyphi A isolated from Rourkela, Orissa.

Authors:  S S Bhattacharya; Usha Das; B K Choudhury
Journal:  Indian J Med Res       Date:  2011-04       Impact factor: 2.375

9.  Paratyphoid fever in India: An emerging problem.

Authors:  S Sood; A Kapil; N Dash; B K Das; V Goel; P Seth
Journal:  Emerg Infect Dis       Date:  1999 May-Jun       Impact factor: 6.883

10.  Antimicrobial susceptibility of Salmonella enterica serovars in a tertiary care hospital in southern India.

Authors:  Ashwini Choudhary; Ram Gopalakrishnan; P Senthur Nambi; V Ramasubramanian; K Abdul Ghafur; M A Thirunarayan
Journal:  Indian J Med Res       Date:  2013-04       Impact factor: 2.375

View more
  5 in total

1.  Clinical Profile and the Role of Rapid Serological Tests: Typhifast IgM and Enterocheck WB in the Diagnosis of Typhoid Fever.

Authors:  Rahul J Bhume; Prakash Babaliche
Journal:  Indian J Crit Care Med       Date:  2020-05

2.  A systematic review of antimicrobial resistance of typhoidal Salmonella in India.

Authors:  Carl D Britto; Jacob John; Valsan P Verghese; Andrew J Pollard
Journal:  Indian J Med Res       Date:  2019-02       Impact factor: 2.375

3.  Extensively Drug-Resistant Typhoid Fever: A Call to Action.

Authors:  Manas Pustake; Purushottam Giri; Sampada Tambolkar; Shreeja Nayak
Journal:  Indian J Community Med       Date:  2022-03-16

4.  Co-trimoxazole versus azithromycin for the treatment of undifferentiated febrile illness in Nepal: study protocol for a randomized controlled trial.

Authors:  Sunil Pokharel; Buddha Basnyat; Amit Arjyal; Saruna Pathak Mahat; Raj Kumar Kc; Abhusani Bhuju; Buddhi Poudyal; Evelyne Kestelyn; Ritu Shrestha; Dung Nguyen Thi Phuong; Rajkumar Thapa; Manan Karki; Sabina Dongol; Abhilasha Karkey; Marcel Wolbers; Stephen Baker; Guy Thwaites
Journal:  Trials       Date:  2017-10-02       Impact factor: 2.279

5.  Glycyrrhizin Attenuates Salmonella enterica Serovar Typhimurium Infection: New Insights Into Its Protective Mechanism.

Authors:  Xiaogang Xu; Li Gong; Baikui Wang; Yanping Wu; Yang Wang; Xiaoqiang Mei; Han Xu; Li Tang; Rongrong Liu; Zhonghua Zeng; Yulong Mao; Weifen Li
Journal:  Front Immunol       Date:  2018-10-16       Impact factor: 7.561

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.